MedTrace Logo

Evaluating the Impact of Patient-Centered Oncology Care

NCT02110758 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 125250

Last updated 2021-03-09

Study results available
· View outcomes & findings →

Summary

The National Committee for Quality Assurance has worked with the National Coalition for Cancer Survivorship, the American Society of Clinical Oncology, Oncology Management Services, Independence Blue Cross, and RAND, as well as a broader multi-stakeholder advisory group, to define the Patient-Centered Oncology Care model. The purpose of this project was to pilot and evaluate this model. Specific research questions were:

1. Does Patient-Centered Oncology Care improve patient experiences and quality of care? Does it reduce undesirable events like emergency department visits and hospital stays?
2. How does adoption of Patient-Centered Oncology Care vary across a variety of practices and what factors affect adoption?

The demonstration occurred in oncology practices in southeastern Pennsylvania. Practices received implementation support during the 24-month demonstration period. They were evaluated using patient surveys, quality measures, and measures of emergency department and hospital use. Results from these practices were compared in two ways: 1) with their performance before they became oncology medical homes and 2) with other similar practices.

Conditions

  • Neoplasms

Interventions

OTHER

Pilot of Patient-Centered Oncology Care

Patient-Centered Oncology Care addresses six domains: track \& coordinate referrals, provide access and communication, identify and coordinate patient populations, plan and manage care, track \& coordinate care, and measure and improve performance.

Sponsors & Collaborators

  • American Society of Clinical Oncology

    collaborator OTHER

  • Independence Blue Cross

    collaborator OTHER

  • National Coalition for Cancer Survivorship

    collaborator UNKNOWN

  • Oncology Management Services

    collaborator UNKNOWN

  • RAND

    collaborator OTHER

  • National Committee for Quality Assurance

    lead OTHER

Principal Investigators

  • Sarah H Scholle, DrPH, MPH · National Committee for Quality Assurance

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-02-28
Primary Completion
2017-01-31
Completion
2017-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02110758 on ClinicalTrials.gov